Novel Neurotherapeutics

The remarkable advances in animal models, genetics, biomarker development, and drug discovery have led to the development of novel neurotherapeutics. Innovative treatments include neurochemical and molecular targets, genes and epigenetic therapies, cognitive construct-based behavioral interventions, as well as neural circuitry-based therapies such as deep brain stimulation and magnetic stimulation.

  • Neurotransmitters, neuromodulators, and neuroreceptors
  • Centrally acting analgesics
  • Blood brain barrier (BBB)
  • Metabolism mediated drug-drug interactions
  • Enzyme kinetics
  • Role of drug metabolism in drug development
  • Neurological Drug Targets

Related Conference of Novel Neurotherapeutics

August 29-31, 2017

15th European Neurology Congress

London, UK
August 29-31, 2017

6th World Congress on Addiction Disorder & Addiction Therapy

Prague, Czech Republic
August 31-September 01, 2017

3rdInternational Conference on Epilepsy and Treatment

Brussels, Belgium
October 16-17, 2017

17th Global Neuroscience Conference

Osaka, Japan
February 22-23, 2018

10th International Conference on Vascular Dementia

Paris, France
July 16-17, 2018

25th World Congress on Neurology and Neurodisorders

Melbourne, Australia
September 17-18, 2018

International Conference on Nervous System and Nerve Diseases

Philadelphia , USA
August 29-30, 2018

4th World Congress on Parkinsons and Huntington Disease

Zurich, Switzerland
September 10-12, 2018

4th International Conference on Spine and Spinal Disorders

Dublin, Ireland
September 17-18, 2018

4th World Congress on Epilepsy and Treatment

Bali, Indonesia
November 5-6, 2018

3rd International Conference on Spine and Spinal Disorder

San Franciso, USA

Novel Neurotherapeutics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in